Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes
Public ClinicalTrials.gov record NCT01080157. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Evaluation of a Noninvasive Diabetes Screening Device in Subjects at Risk for Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this research study is to test the safety and effectiveness of the SCOUT DS in measuring the concentration of substances (advanced glycation endproducts) in the skin. These substances have been found to be in higher concentrations in people with diabetes and high blood sugar. The SCOUT DS is being developed to help doctors measure these substances in skin and possibly help doctors diagnose diabetes.
Study identification
- NCT ID
- NCT01080157
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 509 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2010 (Type not available)
- Primary completion
- Dec 2010 (Actual)
- Completion
- Dec 2010 (Actual)
- Last update posted
- Dec 4, 2012
2010
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Accelovance - Huntsville | Huntsville | Alabama | 35802 | — |
| Accelovance - San Diego, CA | San Diego | California | 92108 | — |
| Radiant Research, Inc. - Chicago | Chicago | Illinois | 60654 | — |
| Accelovance - Peoria, IL | Peoria | Illinois | 61602 | — |
| Radiant Research, Inc. - Kansas City | Kansas City | Kansas | 66202 | — |
| Accelovance - Rockville, MD | Rockville | Maryland | — | — |
| Radiant Research, Inc. - Minneapolis | Minneapolis | Minnesota | 55345 | — |
| Lovelace Scientific Resources, Inc. | Albuquerque | New Mexico | 87108 | — |
| Radiant Research, Inc. - Cincinnati | Cincinnati | Ohio | 45249 | — |
| Juno Research, LLC | Houston | Texas | 77036 | — |
| Dynamed Clinical Research, LP | Houston | Texas | 77375 | — |
| Radiant Research, Inc. - San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01080157, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 4, 2012 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01080157 live on ClinicalTrials.gov.